Quantum simulation drives breakthrough in drug development

FHS
July 31, 2024
4:33 am

Led by University of Melbourne theoretician and HPC expert Associate Professor Giuseppe Barca, a research team has achieved the first quantum simulation of biological systems at a scale necessary to accurately model drug performance.

New research agenda to examine the impact of Dobbs decision on minors

A new report from Youth Reproductive Equity, a national collaborative of researchers and clinicians, outlines a research agenda to examine the impact of the Dobbs

May 9, 2024

Neurocrine axes Takeda-partnered depression program, switches focus for seizure drug after PhII failures

Neurocrine Biosciences has been hit with a pair of mid-stage failures for its partnered candidates in major depressive disorder (MDD) and focal onset seizures (FOS),

November 11, 2023

Research highlights the need for continued surveillance of emerging SARS-CoV-2 variants and vaccines

Researchers at the Francis Crick Institute and the National Institute for Health and Care Research Biomedical Research Centre at UCLH have highlighted the importance of

March 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.